⌘K

Login Start Free

Home/Filings/4/0001213900-24-025520

4//SEC Filing

Eliya Yehuda 4

Accession 0001213900-24-025520

CIK 0001415397other

View on SEC.gov Company Profile

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:01 PM ET

Size

4.5 KB

Accession

0001213900-24-025520

Insider Transaction Report

Form 4

Period: 2023-11-25

Raphael Pharmaceutical Inc.RAPH

Director

Transactions

Award
Common Stock
2023-11-25$0.40/sh+150,000$60,000→ 352,000 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Raphael Pharmaceutical Inc.

CIK 0001415397

Entity typeother

Related Parties

1

filerCIK 0001904163

Filing Metadata

Form type: 4
Filed: Mar 24, 8:00 PM ET
Accepted: Mar 25, 4:01 PM ET
Size: 4.5 KB

View on SEC.gov